Search

everythinglearnresearchcommunity

for

Search:↓

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Calcipotriene ointment improved a child's skin condition known as En coup de sabre.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Peeling skin syndrome was successfully treated with a vitamin D cream.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.